Table 3.

Univariate and multivariate analysis of factors related with overall survival in training set.

	HR	P	95% CI	HR	P	95% CI
Age (>60)	1.042	0.780	0.782–1.387
Gender	1.401	0.088	0.951–2.064
Positive HBsAg	1.133	0.540	0.759–1.692
Positive HBeAg	1.370	0.060	0.987–1.901
Positive HBcAb	0.874	0.744	0.388–1.965
Liver cirrhosis	1.125	0.395	0.857–1.478
Child-Pugh	1.042	0.842	0.692–1.569
Tumor size	1.118	<0.001	1.079–1.159	1.050	0.029	1.005–1.097
Tumor number	1.724	<0.001	1.400–2.215	1.502	<0.001	1.207–1.871
MVI	2.310	<0.001	1.774–3.009	1.772	<0.001	1.338–2.347
Satellite lesions	2.549	<0.001	1.770–3.669	1.857	0.002	1.267–2.722
Differentiation	1.448	0.005	1.121–1.871	1.316	0.040	1.013–1.710
AFP (>400 ng/ml)	1.453	0.004	1.125–1.877
TBIL	0.988	0.259	0.968–1.009
ALT	1.001	0.592	0.998–1.003
AST	1.005	0.004	1.002–1.009
CREA	1.002	0.538	0.996–1.008
INR	1.692	0.419	0.473–6.049
Fibrinogen	1.233	0.002	1.081–1.407
PLR (>167.7)	2.243	<0.001	1.559–3.228	1.862	0.002	1.265–2.739
NLR (>3.1)	1.573	0.002	1.185–2.087
AGR (>0.5)	0.471	<0.001	0.364–0.609	0.673	0.007	0.506–0.896

The bold indicates statistically significant.